NervGen Pharma Corp. (NGEN) — Working Capital to Net Assets Ratio
NervGen Pharma Corp. (NGEN) has a Working Capital to Net Assets ratio of 92.9% as of March 2026. Working capital of $5.14 Million (current assets of $20.36 Million minus current liabilities of $15.21 Million) is measured against net assets of $5.54 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See NGEN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
NervGen Pharma Corp. Working Capital to Net Assets (2018–2025)
This chart shows how NervGen Pharma Corp.'s Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 92.9%, reflecting working capital of $5.14 Million against net assets of $5.54 Million USD. See operational self-sufficiency of NervGen Pharma Corp. to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for NervGen Pharma Corp. (2018–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for NervGen Pharma Corp. from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see NervGen Pharma Corp. market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 88.2% | $3.07 Million | $3.48 Million | $22.80 Million | $19.73 Million | ▲ +6.3 pp |
| 2024 | 82.0% | $2.11 Million | $2.57 Million | $19.00 Million | $16.89 Million | ▼ -48.7 pp |
| 2023 | 130.6% | $-2.62 Million | $-2.01 Million | $12.52 Million | $15.14 Million | ▲ +34.5 pp |
| 2022 | 96.1% | $12.82 Million | $13.34 Million | $22.94 Million | $10.13 Million | ▼ -1.1 pp |
| 2021 | 97.2% | $16.47 Million | $16.95 Million | $17.55 Million | $1.09 Million | ▲ +5.2 pp |
| 2020 | 92.0% | $5.46 Million | $5.93 Million | $6.22 Million | $756.78K | ▲ +0.7 pp |
| 2019 | 91.3% | $5.48 Million | $6.00 Million | $6.43 Million | $949.14K | ▲ +7.7 pp |
| 2018 | 83.6% | $2.09 Million | $2.51 Million | $2.54 Million | $447.45K | — |